PricewaterhouseCoopers' Review of the Office of National Drug Control Policy

Pursuant to a legislative requirement, GAO reviewed PricewaterhouseCoopers' (PwC) assessment of the performance, efficiency, and effectiveness of the Office of National Drug Control Policy's (ONDCP) operations, focusing on whether: (1) ONDCP performs its statutory and regulatory responsibilities in an efficient, effective, and results-oriented manner; (2) ONDCP optimizes human resources in fulfilling its primary objectives of policy, anti-drug program coordination, and compliance; and (3) ONDCP's internal control systems are strategically deployed to enhance business processes throughout the organization.